Alpharma, Inc. (NYSE: ALO), a global specialty pharmaceutical company, has an expanding branded franchise within the U.S. pain market with its KADIAN Capsules and the FLECTOR Patch 1.3%. The company is active in over 80 countries and is known throughout the world as a leading provider of pharmaceutical products for poultry and livestock. For further information, visit the Company’s web site at www.alpharma.com.
- 17 years ago
QualityStocks
Alpharma, Inc. (NYSE: ALO)
Tags Rodman & Renshaw
Related Post
-
Soligenix Inc. (NASDAQ: SNGX) Strengthens Rare Disease Pipeline Program Through UK Regulatory Innovation Designation
Designations granted by leading global regulatory agencies play a critical role in advancing drug-development programs.…
-
Safe Pro Group Inc. (NASDAQ: SPAI) Delivers Critical Security and Defense Solutions to Governments and Organizations
Safe Pro Group delivers AI, drone-based services, and ballistic protective gear, to customers in the…
-
LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape
Recent research shows how chemotherapy and immunotherapy can complement each other when used together. Within…